$NEO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEOGENOMICS INC. Get notifications about new insider transactions in NEOGENOMICS INC for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2020 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Grant | A | 0.00 | 2,698 | 0 | 136,800 | 134.1 K to 136.8 K (+2.01 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Grant | A | 0.00 | 2,698 | 0 | 55,666 | 53 K to 55.7 K (+5.09 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 0.00 | 2,698 | 0 | 48,883 | 46.2 K to 48.9 K (+5.84 %) |
Jun 01 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
Jun 01 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Grant | A | 0.00 | 2,698 | 0 | 197,932 | 195.2 K to 197.9 K (+1.38 %) |
May 27 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 22,330 | 0 | 2,293,743 | 2.3 M to 2.3 M (-0.96 %) |
May 27 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 5,405 | 0 | 146,235 | 151.6 K to 146.2 K (-3.56 %) |
May 04 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | M | 4.78 | 10,000 | 47,800 | 0 | |
May 04 2020 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Buy | M | 4.78 | 10,000 | 47,800 | 46,185 | 36.2 K to 46.2 K (+27.64 %) |
Mar 16 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 4.78 | 125,000 | 597,500 | 0 | |
Mar 16 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 4.78 | 125,000 | 597,500 | 1,500,000 | 1.4 M to 1.5 M (+9.09 %) |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 8.03 | 96,167 | 772,221 | 96,167 | |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 30.86 | 98,093 | 3,027,150 | 151,640 | 249.7 K to 151.6 K (-39.28 %) |
Mar 05 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 8.03 | 96,167 | 772,221 | 249,733 | 153.6 K to 249.7 K (+62.62 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.24 | 20,000 | 564,800 | 30,476 | 50.5 K to 30.5 K (-39.62 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.24 | 2,300 | 64,952 | 40,757 | 43.1 K to 40.8 K (-5.34 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.48 | 25,000 | 712,000 | 125,000 | 150 K to 125 K (-16.67 %) |
Mar 04 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 28.85 | 250,000 | 7,212,500 | 1,375,000 | 1.6 M to 1.4 M (-15.38 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Grant | A | 0.00 | 5,824 | 0 | 12,060 | 6.2 K to 12.1 K (+93.39 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Bonello William | President, Informat ... | Payment of Exercise | F | 0.00 | 499 | 0 | 6,236 | 6.7 K to 6.2 K (-7.41 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | A | 28.33 | 15,006 | 425,120 | 15,006 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Grant | A | 0.00 | 2,330 | 0 | 24,980 | 22.7 K to 25 K (+10.29 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Payment of Exercise | F | 0.00 | 212 | 0 | 22,650 | 22.9 K to 22.7 K (-0.93 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | A | 28.33 | 18,757 | 531,386 | 18,757 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Grant | A | 0.00 | 2,912 | 0 | 43,988 | 41.1 K to 44 K (+7.09 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | A | 28.33 | 48,768 | 1,381,597 | 48,768 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Grant | A | 0.00 | 7,571 | 0 | 333,402 | 325.8 K to 333.4 K (+2.32 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | A | 28.33 | 56,271 | 1,594,157 | 56,271 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Grant | A | 0.00 | 8,736 | 0 | 153,566 | 144.8 K to 153.6 K (+6.03 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 810 | 0 | 144,830 | 145.6 K to 144.8 K (-0.56 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | Weiss Lawrence Martin | Chief Medical Offic ... | Grant | A | 0.00 | 5,824 | 0 | 11,717 | 5.9 K to 11.7 K (+98.83 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | A | 28.33 | 225,084 | 6,376,630 | 225,084 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Grant | A | 0.00 | 34,945 | 0 | 2,316,073 | 2.3 M to 2.3 M (+1.53 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 2,353 | 0 | 2,281,128 | 2.3 M to 2.3 M (-0.10 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Option Exercise | A | 28.33 | 37,514 | 1,062,772 | 37,514 | |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Grant | A | 0.00 | 5,824 | 0 | 7,929 | 2.1 K to 7.9 K (+276.67 %) |
Mar 03 2020 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 168 | 0 | 2,105 | 2.3 K to 2.1 K (-7.39 %) |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | J | 7.15 | 100,000 | 715,000 | 100,000 | |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | J | 7.15 | 100,000 | 715,000 | 0 | |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | M | 4.78 | 100,000 | 478,000 | 125,000 | |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | J | 4.78 | 225,000 | 1,075,500 | 225,000 | |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | J | 4.78 | 225,000 | 1,075,500 | 0 | |
Jan 02 2020 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Buy | M | 4.78 | 100,000 | 478,000 | 1,625,000 | 1.5 M to 1.6 M (+6.56 %) |
Dec 12 2019 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Accounting Of ... | Option Exercise | M | 8.03 | 8,000 | 64,240 | 40,000 | |
Dec 12 2019 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Accounting Of ... | Sell | S | 26.37 | 8,000 | 210,960 | 2,273 | 10.3 K to 2.3 K (-77.87 %) |
Dec 12 2019 | NEO | NEOGENOMICS INC | McKenzie Kathryn B | Chief Accounting Of ... | Buy | M | 8.03 | 8,000 | 64,240 | 10,273 | 2.3 K to 10.3 K (+351.96 %) |
Nov 22 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Gift | G | 24.53 | 50,000 | 1,226,500 | 195,234 | 245.2 K to 195.2 K (-20.39 %) |
Nov 22 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 24.27 | 23,162 | 562,142 | 1,525,000 | 1.5 M to 1.5 M (-1.50 %) |
Nov 22 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 24.35 | 128,068 | 3,118,456 | 1,548,162 | 1.7 M to 1.5 M (-7.64 %) |
Nov 21 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 24.08 | 187,500 | 4,515,000 | 0 | 187.5 K to 0 (-100.00 %) |
Nov 18 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 8.03 | 166 | 1,333 | 48,334 | |
Nov 18 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Option Exercise | M | 7.52 | 6,667 | 50,136 | 20,000 | |
Nov 18 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Sell | S | 23.45 | 6,833 | 160,234 | 22,862 | 29.7 K to 22.9 K (-23.01 %) |
Nov 18 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 8.03 | 166 | 1,333 | 29,695 | 29.5 K to 29.7 K (+0.56 %) |
Nov 18 2019 | NEO | NEOGENOMICS INC | BALLIET JENNIFER | VP and Chief Cultur ... | Buy | M | 7.52 | 6,667 | 50,136 | 29,529 | 22.9 K to 29.5 K (+29.16 %) |
Nov 14 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.15 | 44,444 | 317,775 | 100,000 | |
Nov 14 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 23.15 | 19,444 | 450,129 | 325,831 | 345.3 K to 325.8 K (-5.63 %) |
Nov 14 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.15 | 44,444 | 317,775 | 345,275 | 300.8 K to 345.3 K (+14.77 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.15 | 472,527 | 3,378,568 | 0 | |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 205,635 | 0 | 2,277,391 | 2.5 M to 2.3 M (-8.28 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.15 | 472,527 | 3,378,568 | 2,483,026 | 2 M to 2.5 M (+23.50 %) |
Nov 13 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 6,090 | 0 | 2,010,499 | 2 M to 2 M (-0.30 %) |
Nov 08 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.15 | 55,556 | 397,225 | 144,444 | |
Nov 08 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 22.80 | 4,000 | 91,200 | 300,831 | 304.8 K to 300.8 K (-1.31 %) |
Nov 08 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 22.82 | 51,556 | 1,176,508 | 304,831 | 356.4 K to 304.8 K (-14.47 %) |
Nov 08 2019 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.15 | 55,556 | 397,225 | 356,387 | 300.8 K to 356.4 K (+18.47 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | M | 11.60 | 3,017 | 34,997 | 0 | |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | M | 7.27 | 6,666 | 48,462 | 3,334 | |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | M | 9.11 | 8,333 | 75,914 | 0 | |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | M | 4.78 | 6,667 | 31,868 | 0 | |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 11.60 | 3,017 | 34,997 | 52,968 | 50 K to 53 K (+6.04 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 7.27 | 6,666 | 48,462 | 49,951 | 43.3 K to 50 K (+15.40 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 9.11 | 8,333 | 75,914 | 43,285 | 35 K to 43.3 K (+23.84 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Buy | M | 4.78 | 6,667 | 31,868 | 34,952 | 28.3 K to 35 K (+23.57 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Option Exercise | M | 8.03 | 96,166 | 772,213 | 192,334 | |
Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 22.74 | 35,801 | 814,115 | 145,640 | 181.4 K to 145.6 K (-19.73 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Sell | S | 23.11 | 70,473 | 1,628,631 | 181,441 | 251.9 K to 181.4 K (-27.98 %) |
Nov 04 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Buy | M | 8.03 | 96,166 | 772,213 | 251,914 | 155.7 K to 251.9 K (+61.74 %) |
Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 9.11 | 8,333 | 75,914 | 0 | |
Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 6.66 | 3,333 | 22,198 | 0 | |
Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 9.11 | 8,333 | 75,914 | 76,098 | 67.8 K to 76.1 K (+12.30 %) |
Sep 11 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 6.66 | 3,333 | 22,198 | 67,765 | 64.4 K to 67.8 K (+5.17 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Gift | G | 0.00 | 3,400 | 0 | 43,057 | 46.5 K to 43.1 K (-7.32 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 21.47 | 1,200 | 25,764 | 46,457 | 47.7 K to 46.5 K (-2.52 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Gift | G | 0.00 | 3,400 | 0 | 43,057 | 46.5 K to 43.1 K (-7.32 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.00 | 3 | 75 | 1,676,230 | 1.7 M to 1.7 M (0.00 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 21.47 | 1,200 | 25,764 | 46,457 | 47.7 K to 46.5 K (-2.52 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.00 | 1,691 | 42,275 | 1,676,233 | 1.7 M to 1.7 M (-0.10 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.00 | 3 | 75 | 1,676,230 | 1.7 M to 1.7 M (0.00 %) |
Sep 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.00 | 1,691 | 42,275 | 1,676,233 | 1.7 M to 1.7 M (-0.10 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,016,589 | 2 M to 2 M (-0.49 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 10,000 | 0 | 2,026,589 | 2 M to 2 M (-0.49 %) |
Sep 03 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Gift | G | 0.00 | 30,000 | 0 | 2,036,589 | 2.1 M to 2 M (-1.45 %) |
Aug 30 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Option Exercise | M | 7.52 | 17,000 | 127,840 | 55,763 | |
Aug 30 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Sell | S | 24.83 | 17,000 | 422,110 | 6,735 | 23.7 K to 6.7 K (-71.62 %) |
Aug 30 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Buy | M | 7.52 | 17,000 | 127,840 | 23,735 | 6.7 K to 23.7 K (+252.41 %) |
Aug 30 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.00 | 1,200 | 30,000 | 1,677,924 | 1.7 M to 1.7 M (-0.07 %) |
Aug 30 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.02 | 39,537 | 989,216 | 1,679,124 | 1.7 M to 1.7 M (-2.30 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 11.60 | 3,017 | 34,997 | 0 | |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 7.27 | 3,333 | 24,231 | 3,334 | |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | M | 9.11 | 2,777 | 25,298 | 0 | |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Sell | S | 24.79 | 15,424 | 382,361 | 134,102 | 149.5 K to 134.1 K (-10.32 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Sell | S | 25.02 | 600 | 15,012 | 149,526 | 150.1 K to 149.5 K (-0.40 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 9.11 | 2,777 | 25,298 | 150,126 | 147.3 K to 150.1 K (+1.88 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 7.27 | 3,333 | 24,231 | 147,349 | 144 K to 147.3 K (+2.31 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Buy | M | 11.60 | 3,017 | 34,997 | 144,016 | 141 K to 144 K (+2.14 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Sell | S | 24.74 | 11,800 | 291,932 | 28,285 | 40.1 K to 28.3 K (-29.44 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Sell | S | 25.60 | 41,200 | 1,054,720 | 40,085 | 81.3 K to 40.1 K (-50.69 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 24.95 | 30,280 | 755,486 | 1,718,661 | 1.7 M to 1.7 M (-1.73 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 24.87 | 143,603 | 3,571,407 | 1,748,941 | 1.9 M to 1.7 M (-7.59 %) |
Aug 27 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Sell | S | 25.72 | 7,456 | 191,768 | 1,892,544 | 1.9 M to 1.9 M (-0.39 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 3,419 | 0 | 41,653 | 38.2 K to 41.7 K (+8.94 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 3,419 | 0 | 41,653 | 38.2 K to 41.7 K (+8.94 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Grant | A | 0.00 | 3,419 | 0 | 3,419 | 0 to 3.4 K |
Jun 10 2019 | NEO | NEOGENOMICS INC | KANOVSKY STEPHEN M | Director | Grant | A | 0.00 | 3,419 | 0 | 3,419 | 0 to 3.4 K |
Jun 10 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Grant | A | 0.00 | 3,419 | 0 | 81,285 | 77.9 K to 81.3 K (+4.39 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | Johnson Kevin C | Director | Grant | A | 0.00 | 3,419 | 0 | 81,285 | 77.9 K to 81.3 K (+4.39 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 0.00 | 3,419 | 0 | 36,185 | 32.8 K to 36.2 K (+10.43 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | CROWTHER BRUCE K | Director | Grant | A | 0.00 | 3,419 | 0 | 36,185 | 32.8 K to 36.2 K (+10.43 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 3,419 | 0 | 64,432 | 61 K to 64.4 K (+5.60 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 3,419 | 0 | 64,432 | 61 K to 64.4 K (+5.60 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Grant | A | 0.00 | 3,419 | 0 | 140,999 | 137.6 K to 141 K (+2.49 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Grant | A | 0.00 | 3,419 | 0 | 140,999 | 137.6 K to 141 K (+2.49 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
Jun 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Grant | A | 0.00 | 3,419 | 0 | 245,234 | 241.8 K to 245.2 K (+1.41 %) |
Jun 10 2019 | NEO | NEOGENOMICS INC | JONES STEVEN C | Director | Grant | A | 0.00 | 3,419 | 0 | 245,234 | 241.8 K to 245.2 K (+1.41 %) |
May 29 2019 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Payment of Exercise | F | 0.00 | 25,846 | 0 | 2,066,589 | 2.1 M to 2.1 M (-1.24 %) |
May 29 2019 | NEO | NEOGENOMICS INC | SHOVLIN ROBERT J. | President, Clinical ... | Payment of Exercise | F | 0.00 | 6,559 | 0 | 155,748 | 162.3 K to 155.7 K (-4.04 %) |
May 09 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Sell | S | 22.36 | 118,479 | 2,649,190 | 137,580 | 256.1 K to 137.6 K (-46.27 %) |
May 09 2019 | NEO | NEOGENOMICS INC | HIPP RAYMOND R | Director | Sell | S | 22.61 | 31,521 | 712,690 | 256,059 | 287.6 K to 256.1 K (-10.96 %) |
May 08 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Option Exercise | M | 7.52 | 7,200 | 54,144 | 72,763 | |
May 08 2019 | NEO | NEOGENOMICS INC | Bonello William | Chief Strategy Offi ... | Sell | S | 23.53 | 7,200 | 169,416 | 6,735 | 13.9 K to 6.7 K (-51.67 %) |